This stage is where long term success is built
When lost quickly, the underlying scaffolding disappears, and the skin as well as the supporting collagen and elastin may not adapt in time, leading to sagging, deeper folds, and a deflated appearance often described as Ozempic face. Common facial changes associated with GLP-1-driven weight loss include: Sunken cheeks and temples Sagging jowls and jawline Deepening of nasolabial folds (smile lines) Downturned corners of the mouth Flattened or elongated lips Excess skin and loss of facial volume These changes result not only from fat loss but also from the skins decreased elasticity that occurs with both aging and accelerated weight reduction
DPP-4 inhibitors work by blocking an enzyme that breaks down incretin hormones, including GLP-1
Under 503A, a state-licensed compounding pharmacy can prepare patient-specific semaglutide or tirzepatide formulations when a prescriber documents a clinically significant difference from the commercial product, for example an intolerance-driven microdose titration or a preservative-free formulation
Barbra Streisand asked Melissa McCarthy if she'd taken Ozempic, and she didn't confirm or deny
She encourages practitioners to frame GLP-1 therapies as tools to jumpstart change, not as long-term solutions
.png)
